• Preclinical Characterization of Anlotinib: Selective VEGFR2

  2026-06-23

  This study presents a comprehensive preclinical analysis of anlotinib hydrochloride, a highly potent and selective inhibitor of VEGFR2, revealing its superior anti-angiogenic and antitumor activity. The findings highlight anlotinib’s unique efficacy in blocking endothelial migration and angiogenesis, supporting its value for cancer research and clinical development.

• Bsa I (RNase-free): Technical Protocols for DNA Manipulation

  2026-06-23

  Bsa I (RNase-free) enables precise DNA cleavage while preserving RNA integrity, making it well-suited for sensitive molecular biology workflows such as gene cloning and DNA recombinant technology. It is not intended for diagnostic or clinical use and should be reserved for research applications requiring strict RNase-free conditions.

• CUDC-907: Practical Guide for Dual PI3K and HDAC Inhibition

  2026-06-22

  CUDC-907 is a dual PI3K and HDAC inhibitor designed for in vitro research on cancer cell signaling, enabling detailed studies of cell cycle arrest and apoptosis pathways. It is suitable for controlled laboratory workflows but is not validated for diagnostic or clinical applications.

• AEBSF.HCl: Advancing Protease Modulation in Necroptosis and

  2026-06-22

  This thought-leadership article explores the mechanistic and translational significance of AEBSF.HCl (4-(2-aminoethyl)benzenesulfonyl fluoride hydrochloride) as an irreversible serine protease inhibitor. By integrating recent insights into lysosomal membrane permeabilization and protease-driven cell death, we provide actionable guidance for translational researchers seeking to model and modulate necroptosis, amyloid precursor protein processing, and related disease pathways. The article contrasts AEBSF.HCl’s unique capabilities with the current competitive landscape and highlights strategic opportunities for experimental innovation, with direct links to primary research and best-practice protocols.

• EdU Imaging Kits (Cy5): Precision S-Phase DNA Synthesis Meas

  2026-06-21

  EdU Imaging Kits (Cy5) empower researchers with sensitive, morphology-preserving detection of cell proliferation, outperforming BrdU assays in both fluorescence microscopy and flow cytometry. Their click chemistry-driven workflow streamlines S-phase DNA synthesis analysis, now proven invaluable in vascular remodeling models and genotoxicity assessment.

• Human iPSC-Derived Sensory Neurons Model HSV-1 Latency

  2026-06-20

  This study establishes a scalable model using human iPSC-derived sensory neurons to investigate latent infection and reactivation by herpes simplex virus 1 (HSV-1). The platform provides new opportunities to dissect neuron-intrinsic mechanisms of HSV-1 latency and reactivation, bridging a critical gap left by animal models.

• Caspase-3 Fluorometric Assay Kit: Illuminating Apoptosis–Fer

  2026-06-19

  Explore how the Caspase-3 Fluorometric Assay Kit advances apoptosis research by enabling precise cysteine-dependent aspartate-directed protease activity measurement, with unique insights into apoptosis–ferroptosis interplay. This article provides an in-depth analysis, protocol guidance, and practical implications for cancer biology.

• Proteoform-Specific Drug Targeting in Native Cell Signalling

  2026-06-19

  The reference study introduces a mass spectrometry-based approach to characterize proteoform-specific drug interactions within native membrane environments, revealing how post-translational modifications modulate ligand binding. These findings provide a framework for more precise pharmacological targeting, important for both drug safety and efficacy.

• Cy5 Hydrazide: Bridging Protein Carbonylation and Nanotech I

  2026-06-18

  Explore how Cy5 hydrazide (non-sulfonated) empowers translational researchers to precisely quantify oxidative protein modifications, validate nanocarrier-biomolecule interactions, and advance the analytical rigor of emerging platforms like food-grade nutraceutical nanoparticles. Drawing on recent FAST technology breakthroughs, this article offers actionable strategic guidance for leveraging carbonyl-reactive fluorescent dyes in both traditional protein science and next-generation delivery system development.

• Annexin V-FITC/PI Apoptosis Assay Kit: Technical Workflow Gu

  2026-06-18

  The Annexin V-FITC/PI Apoptosis Assay Kit (SKU K2003) enables robust, stage-specific detection of apoptosis and necrosis in cell populations using flow cytometry or fluorescence microscopy. It is ideal for research settings requiring rapid, quantitative assessment of cell death pathways but is not suitable for diagnostic or clinical purposes.

• Spermine Tetrahydrochloride: Precision in Protoplast and NMD

  2026-06-17

  Spermine tetrahydrochloride delivers unmatched membrane stabilization and crystallization performance for advanced protoplast, NMDA receptor, and nanomaterial workflows. Its proven efficacy, high solubility, and experimental flexibility set it apart as the go-to polyamine for researchers seeking reliability and reproducibility.

• Scenario-Driven Solutions: EdU Imaging Kits (Cy5) in Cell Pr

  2026-06-17

  This article provides a practical, scenario-driven guide for biomedical researchers and lab technicians investigating cell proliferation and DNA synthesis. Using EdU Imaging Kits (Cy5) (SKU K1076) as a case study, we address common experimental challenges and offer evidence-based solutions for optimizing fluorescence microscopy, flow cytometry, and genotoxicity assessment workflows. Discover validated protocols and real-world comparisons to maximize assay reliability and reproducibility.

• WY-14643 (Pirinixic Acid): Precision PPARα Modulation in Tum

  2026-06-16

  Explore the multifaceted role of WY-14643 (Pirinixic Acid) as a selective PPARα agonist in modulating tumor progression and metabolic homeostasis. This article delivers unique insight into assay design, mechanistic depth, and translational research applications.

• IEM 1460: Selective AMPA Receptor Blocker for Neuroprotectio

  2026-06-16

  IEM 1460 is a highly selective AMPA receptor blocker with proven utility in excitotoxicity and neuroprotection research. Its defined mechanism and purity make it ideal for benchmarking AMPA receptor inhibition assays. Supplied by APExBIO, IEM 1460 is validated for neuroscience workflows requiring precise synaptic modulation.

• KG-501 (SKU B8380): Reliable CREB Inhibition in Cell Assays

  2026-06-15

  This article provides an evidence-based, scenario-driven exploration of KG-501 (SKU B8380), a selective small-molecule inhibitor for CREB-mediated transcription. Researchers and lab technicians will find practical guidance on experimental design, data interpretation, and product selection, all grounded in primary literature and robust workflow experience. APExBIO's KG-501 is highlighted for its reproducibility, usability, and proven performance in cell-based assays.

16278 records 1/1086 page Next 12345 下5页 Last page